Coronary Artery Calcium to Improve the Efficiency of Randomized Controlled Trials in Primary Cardiovascular Prevention | Zendy

Miguel CainzosAchirica | Zendy; Márcio Sommer Bittencourt | Zendy; Albert D. Osei | Zendy; Waqas Haque | Zendy; Deepak L. Bhatt | Zendy; Roger S. Blumenthal | Zendy; Ron Blankstein | Zendy; Kausik K. Ray | Zendy; Michael J. Blaha | Zendy; Khurram Nasir | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Coronary Artery Calcium to Improve the Efficiency of Randomized Controlled Trials in Primary Cardiovascular Prevention

Author(s) -

Miguel CainzosAchirica,

Márcio Sommer Bittencourt,

Albert D. Osei,

Waqas Haque,

Deepak L. Bhatt,

Roger S. Blumenthal,

Ron Blankstein,

Kausik K. Ray,

Michael J. Blaha,

Khurram Nasir

Publication year - 2020

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2020.10.016

Subject(s) - medicine , coronary artery calcium , randomized controlled trial , statin , incidence (geometry) , primary prevention , population , physical therapy , coronary artery disease , cardiology , disease , environmental health , physics , optics

This study sought to assess the value, in terms of sample size and cost, of using the coronary artery calcium (CAC) score to enrich the study population of primary prevention randomized controlled trials (RCTs) with participants at high absolute risk of atherosclerotic cardiovascular disease (ASCVD) events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research